The keywords T1DM, GLP-1 agonists, weight, HbA1c, hyperglycemia, adverse effects, hypoglycemia, time in the range, continuous monitoring, blood glucose, C-peptide, and complications were used. This evidence concerns the gene GCG and Hyperglycemia.